Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
Open Access
Abstract
Dyslipidaemias result in the deposition of cholesterol and lipids in the walls of blood vessels, chronic inflammation and the formation of atherosclerotic plaques, which impede blood flow and (when they rupture) result in acute ischaemic episodes. Whilst recent years have seen enormous success in the reduction of cardiovascular risk using conventional pharmaceuticals, there is increasing interest amongst patients and practitioners in the use of nutraceuticals to combat dyslipidaemias and inflammation in cardiovascular disease. Nutraceutical is a portmanteau term: ‘ceutical’ indicate pharmaceutical-grade preparations, and ‘nutra’ indicates that the products contain nutrients from food. Until relatively recently, little high-quality evidence relating to the safety and efficacy of nutraceuticals has been available to prescribers and policymakers. However, as a result of recent randomised-controlled trials, cohort studies and meta-analyses, this situation is changing, and nutraceuticals are now recommended in several mainstream guidelines relating to dyslipidaemias and atherosclerosis. This article will summarise recent clinical-practice guidance relating to the use of nutraceuticals in this context and the evidence which underlies them. Particular attention is given to position papers and recommendations from the International Lipid Expert Panel (ILEP), which has produced several practical and helpful recommendations in this field.Keywords
This publication has 62 references indexed in Scilit:
- Interpretation of the evidence for the efficacy and safety of statin therapyThe Lancet, 2016
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)Canadian Journal of Cardiology, 2016
- Reincarnated medicines: using out-dated drugs for novel indicationsEuropean Heart Journal, 2016
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine, 2015
- Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert PanelArchives of Medical Science, 2015
- A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for DyslipidemiaPLOS ONE, 2014
- A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trialsProstaglandins, Leukotrienes and Essential Fatty Acids, 2011
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial InfarctionThe American Journal of Cardiology, 2008
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966